2nd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$90,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations for patients with rare diseases. Food and Drug Administration Appropriations. National Institutes of Health (NIH) Appropriations. CDC Appropriations.

LobbyistCovered position, as disclosed
MICHELLE ADAMS —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Drug Pricing. Pediatric Priority Review Vouchers.

LobbyistCovered position, as disclosed
MICHELLE ADAMS —
CORINNE ALBERTS New —
HEIDI ROSS New —
RACHEL L. SHER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Health issues impacting patients with rare diseases. International Classification of Diseases (ICD-10). FDA Clinical Trials Step Therapy. Gene Therapy. Biosimilars. Medical Foods. Public Law No: 111-148: The Patient Protection and Affordable Care Act. HHS/OCR Anti discrimination. Health Care Access Affordability. Surprise Medical Billing. Value Based Purchasing. Paid Leave. COVID-19 Related Issues. COVID-19 Related Home Infusion Issues. Implementation of H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act (CARES) Act.

LobbyistCovered position, as disclosed
MICHELLE ADAMS —
CORINNE ALBERTS New —
HEIDI ROSS New Professional Staff Member-House Foreign Affairs Committee; Sr. Policy Advisor-Rep. Eliot L. Engel; Health Policy Advisor-Rep. Elijah E. Cummings; Legislative Assistant- Rep. Charles A. Wilson; Legislative Correspondent-Senator John D. Rockefeller IV
RACHEL L. SHER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH)

Bills named: H.R. 748 (116th), S. 3548 (116th)

Medicare/Medicaid MMM

Medicare issues impacting patients with rare diseases. Medicare Part A Program. COVID-19 Relief for Home Infusion Under Medicare Part B. Medicare Part D Program. Medicaid Best Price. Section 1115 Medicaid Waivers. Medicaid Block Grants.

LobbyistCovered position, as disclosed
MICHELLE ADAMS —
CORINNE ALBERTS New —
HEIDI ROSS New —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.